Exclusive Interview with 22nd Century Group CEO Jim Mish 22nd Century Group (NASDAQ: XXII) is a plant-based biotechnology that operates three business segments: tobacco, cannabis/hemp and hops. The company aims to stabilize new plant strains and bring them to market. It started in the tobacco space and then moved... Read more

Canopy Growth Announces Divestiture of Canadian Retail Operations Decision supports the Company’s strategic objectives including streamlining Canadian operations, achieving profitability, and advancing a premium brand-driven portfolio for consumers SMITHS FALLS, ON, Sept. 27, 2022 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) announced today that the Company... Read more

iPower Reports Fiscal Fourth Quarter and Full Year 2022 Results Fiscal Q4 Revenue up 50% to a Record $22.1 Million Fiscal 2022 Revenue up 47% to a Record $79.4 Million iPower Management to Host Conference Call Today at 4:30 p.m. Eastern Time DUARTE, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE)... Read more